Home > Insider Trading > Filing (0001181431-13-041478)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1482080	Cellular Dynamics International Inc.	ICEL	Biological Products, (No Disgnostic Substances) (2836)	261737267

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1505628	2 Trust 8-26-22 Texas	C/O 1922 Trust Company Lta, Trustee 3555 Timmons Lane, Suite 800 Houston TX 77027	Yes	No	Yes	No
1553752	8-26-22 Gp Llc	C/O Lewis M. Linn, Manager 3555 Timmons Lane, Suite 800 Houston TX 77027	Yes	No	Yes	No
1582308	Sixth Floor Investors Lp	3555 Timmons Lane, Suite 800 Houston TX 77027	Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value Per Share ("Common Stock")	Acquisiton	2013-07-24	40,000	$12.00	2,091,282	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

In addition to Sixth Floor Investors LP, a Delaware limited partnership ("Sixth Floor Investors"), this Form 4 is being filed jointly by 8-26-22 GP LLC, a Delaware limited liability company ("8-26-22") and Texas 8-26-22 Trust 2 ("Texas 8-26-22", and together with Sixth Floor Investors and 8-26-22, the "Reporting Persons"), each of whom may be deemed to have a pecuniary interest in securities owned by Sixth Floor Investors.
Sixth Floor Investors holds directly the securities set forth in this Form 4 (the "Subject Securities"). As the general partner of Sixth Floor Investors, 8-26-22 may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a). As the sole member of 8-26-22, Texas 8-26-22 may be deemed to be the beneficial owner of the Subject Securities for purposes of Rule 16a-1(a).
Each of the Reporting Persons disclaims any beneficial ownership of any of the securities listed in this Form 4, except to the extent of any pecuniary interest therein.